Bonds News
Monday, July 18, 2016
Teva Pharm prices $15 bln in notes to fund Allergan generics deal
TEL AVIV, July 19 (Reuters) - Teva Pharmaceutical Industries
Ltd said on Tuesday it successfully priced a debt
offering for $15 billion worth of senior notes to help fund its
acquisition of Allergan...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment